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Summary. Objective. The pathogenesis of esophageal atresia (EA) remains unknown despite 
a relatively high incidence of this anomaly in population affecting 1 newborn per 3000 live births. 
The aim of this study was to examine the relative occurrence of growth factors, their receptors, neu-
ropeptide-containing innervation, and tissue-degradating enzymes – matrix metalloproteinases – in 
the proximal and distal parts of the esophagus with EA.
Materials and Methods. A histopathological study was conducted on 15 patients with EA. Tis-
sues were processed for NGFRp75, PGP 9.5, TGF-β, FGFR, VEGF, EGFR and MMP-2 by means 
of biotin-streptavidin immunohistochemistry.
Results. In the control and EA-affected distal esophageal specimens, numerous and abundant 
NGFR-containing structures were detected, while in the proximal part of the esophagus, a de-
crease in their number was observed in patients. PGP 9.5 also marked neuronal structures simi-
larly. TGF-β was found only in occasional cells in the EA-affected esophageal specimens, while 
control material demonstrated moderate to numerous TGF-β-containing structures. Abundance of 
FGFR and only occasional appearance of VEGF-positive cells were found in both the control and 
EA-affected material. A moderate number of connective tissue cells in controls contained EGFR. 
Compared with controls, the number of MMP-2 expressing cells in the EA-affected tissues was 
decreased in the proximal esophagus.
Conclusions. A decrease in PGP 9.5-containing neuronal structures in the proximal esophagus 
supports insufficient innervation of this part of the organ in EA. A decrease in MMP-2 positive cells 
in the esophageal atresia-affected proximal esophagus indicates also a possible decrease of tissue 
adaptive and regenerative reactions. Low expression of TGF-β and almost the absence of EGFR 
in the EA-affected specimens may result in disturbances of cell growth, proliferation, and differen-
tiation, indicating a significant role of these substances in morphopathogenesis of EA. FGFR and 
VEGF seem not to characterize EA pathogenesis.
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introduction
Esophageal atresia (EA) is a rather frequent con-
genital disease affecting 1 per 3000 newborns (1). 
In Latvia, 41 newborns were operated on due to EA 
from 1996 to 2003 (2).
Rather often, EA is revealed together with con-
genital abnormalities of other organs and systems, 
such as heart, digestive system, reproductive sys-
tem, excretory organs, as well as skeleton and nerve 
system. In older patients, gastroesophageal reflux is 
frequently observed. A study by Li et al. has shown 
the imbalance of neurotransmitter excretion in 
nerve vesicles, abnormal intrinsic dysplasia of nerve 
plexus, and increased expression of certain neuro-
peptides as the main characteristics of esophagus 
with abnormal intrinsic innervation, which may be 
responsible for the postoperative esophageal dys-
function in EA (3).
In histological studies, both muscle hypertro-
phy and chaotic organization of the esophagus 
blind end are the most frequently mentioned (4). 
Sometimes, the remnants of tracheobronchial wall, 
such as cartilage and altered mucoserous glands, are 
found in the distal end of the esophagus. Likewise 
the smooth muscle disorganization was observed 
(1) as well as disturbances of both blood supply and 
innervation. 
However, morphopathogenesis of EA is still not 
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understood at the molecular level. Within the last 
decade, much attention has been paid to the role of 
growth factors (5, 6), cell adhesion molecules (7), 
genes (8), and apoptosis (9) in the development of 
EA. In particular, the importance of bone morpho-
genetic protein (BMP) and sonic hedgehog protein 
(Shh) for the development of pathology has been 
investigated.
Despite the regulation of many functions in es-
ophageal structures by neuropeptides, there are still 
incomplete data about the neuropeptide-containing 
innervation in EA. Protein gene product 9.5 (PGP 
9.5) is a cytoplasmic neuron- and neuroendocrine 
cell-specific protein used to visualize the diffuse 
neuroendocrine system – neuropeptide-containing 
innervation (10). In healthy esophageal tissues, the 
stained nerve tissue forms a nearly complete ring, 
while in EA-affected tissues, neuronal elements are 
distributed in a form of isolated clusters of diffuse 
localization (11).
Fibroblast growth factor (FGF) affects cell prolif-
eration, regulates cell growth and maturation (12) as 
well as embryogenesis (13).  
Transforming growth factor β (TGF-β) controls 
the rates of cell growth and proliferation, stimulates 
cell maturation (14) as well as affects the formation 
of extracellular matrix (15). TGF-β is widely inves-
tigated in other esophageal anomalies and diseases.
Vascular endothelial growth factor (VEGF) stim-
ulates endothelial proliferation, particularly under 
hypoxia (16).
Epidermal growth factor receptor (EGFR) is 
found in the tissues of epithelial, mesenchymal, and 
neuronal origin where they contribute to cell prolif-
eration, differentiation, and maturation (17). Matrix 
metalloproteinases (MMPs) catalyze restructuring 
extracellular matrixes. They are the major pro-
teolytic enzymes involved in extracellular matrix 
turnover. MMP-2 (gelatinase A) is one of the fac-
tors that cleaves type IV collagen – an important 
constituent of the basement membrane. MMPs play 
an important role in normal tissue homeostasis, but 
imbalance between those enzymes and their tis-
sue inhibitors (TIMPs) is thought to be a critical 
factor in regulating tissue remodeling. MMP-2 is 
produced by fibroblasts, endothelial and epithelial 
cells, while MMP-9 – a second important proteo-
lytic enzyme – is mainly produced by inflammatory 
cells (18).
Since morphopathological mechanisms of EA 
development are still obscure, the present study was 
aimed to investigate a relative occurrence of growth 
factors, their receptors, neuropeptide-containing in-
nervation and tissue-degradating enzymes, MMPs, 
in the proximal and distal parts of the esophagus 
with EA.
Material and Methods
Material. The specimens were obtained from 15 
newborns (9 boys and 6 girls). In 13 cases, the di-
agnosis of EA with distal tracheoesophageal fistula 
(TEF) was established, while 2 cases were found to 
have EA with proximal TEF. The newborns ranged 
in age from 21 hours to 1 month. In the control 
group, 12 specimens of the esophagus obtained 
from newborns whose cause of death was not relat-
ed to gastrointestinal pathology were included. All 
tissue specimens were obtained in accordance with 
the ethical requirements of Riga Stradins University 
(state permission No. Iz2007/02/11).
Methods. Biotin-Streptavidin Immunohistochem-
istry (19). The tissue fragments were fixed for 24 
hours in a mixture consisting of 2% formaldehyde 
and 0.2% picric acid in 0.1-M phosphate buffer 
(pH 7.2). The tissue fragments were washed for 12 
hours in phosphate buffer (pH 7) containing 10% 
sucrose. Then tissues were embedded in paraffin, 
and the blocks of paraffinized tissues were sec-
tioned into slides 6–7-μm in thickness by means 
of a microtome. The slides were deparaffinized and 
prepared to detect the following growth factors and 
their receptors: NGFR p75 (code M3507, working 
dilution 1:150, Dako, USA), fibroblast growth factor 
receptor 1, FGFR1 (code ab10646, working dilution 
1:100, Cambridge Science Park, UK); TGF-β (code 
ab1279, working dilution 1:1000, Cambridge Science 
Park, UK); VEGF (code M7273, working dilution 
1:50, Dako, Denmark); epidermal growth factor re-
ceptors, EGFR (code M3563, working dilution 1:200, 
Dako, USA); innervation marker, PGP 9.5 (code 
Z5116, working dilution 1:200, Dako, Denmark); and 
tissue-degradating enzyme, MMP-2 (code AF902, 
working dilution 1:50, RD Systems, UK).
Histology. To obtain an overview picture, the 
slides were prepared from each material sample and 
stained with hematoxylin/eosin.
Quantification of Structures. For quantification 
of structures, the semiquantitive counting method 
was used. The designations were as follows: 0, nega-
tive reaction; 0/+, occasionally marked structures 
in the view field; +, a few positive structures in the 
view field; ++, a moderate number of marked struc-
tures in the view field; +++, a numerous number of 
marked structures in the view field; ++++, abun-
dance of marked structures found in the view field 
(20, 21). The semiquantitative evaluation of speci-
mens was performed by using a Leica DM R HC 
microscope (magnification ×250). 
Additionally, the nonparametric Kruskal-Wallis 
test was used to analyze the data (22).
results
In the control specimens, NGFRs were detected 
in abundance in epithelial basal cells (Fig. 1), nerve 
Māra Pilmane, Linda Ozoliņa, Zane Ābola, et al.
455
Medicina (Kaunas) 2011;47(8)
fiber bundles (Fig. 2), smooth muscle cells of small 
blood vessels as well as in nerve fibers around and in 
lymphatic tissues. NGFR expression was also abun-
dant in Meissner’s and Auerbach’s nerve plexuses. 
In the EA-affected tissues, the similar pattern of 
NGFR distribution was observed in the distal es-
ophagus (Fig. 3), even though the nerve plexuses 
were discerned only in some specimens because of 
deranged and chaotic muscle layer. The number of 
NGFR-stained epithelial cells in surface epithelium 
varied from numerous to abundant (Fig. 4) (Table).
In the proximal end wall, the number of NGFR-
positive structures (basal epithelial cells and fine 
nerve fibers) was low (+) in 1 case, and moderate 
and numerous in 13 cases, while abundant number 
of positive cells was noticed only in 4 cases. 
In the EA-affected tissues, moderate and numer-
ous PGP 9.5-containing nerve fibers and bundles 
were detected around small blood vessels, within 
their walls, and inside the intermuscular nerve plex-
us (Fig. 5). The proximal esophagus showed a mod-
erate number of PGP 9.5-containing nerves, while 
the nerves positive for this neuropeptide in the dis-
tal part of the esophagus were numerous. Within the 
esophageal epithelium, PGP 9.5-positive cells were 
not seen. In the control group, the numerous and 
abundant number of PGP 9.5-containing nerve fib-
ers was observed (Fig. 6).
Comparing the numbers of structures express-
ing NGFR and neuronal structures containing PGP 
9.5, a simultaneous increase in both of them was 
documented (Table). In the EA-affected cases, the 
abovementioned structures were mainly observed in 
moderate and numerous numbers. In cases of abun-
dant PGP 9.5 expression, the number of NGFR-
positive structures also increased.
In the control material, the number of TGF-β-
positive structures varied from moderate to numer-
ous (Fig. 7) in connective tissue and endothelium. 
Commonly, TGF-β was found only in occasion-
al cells of the EA-affected esophagus. Only in one 
case, it was observed in the moderate number of 
endothelial cells (Fig. 8). 
FGFR was found in abundance in both control 
and EA-affected specimens. FGFR was expressed 
by fibroblasts, macrophages, blood vessel en-
dothelial cells, leukocytes, lymphocytes as well as 
nerve fibers. Comparison of FGFR expression with 
TGF-β one established a reciprocal dependence be-
tween these two factors, such as decrease of TGF-β-
containing cell number coming along with enlarged 
FGFR expression.
A very weak VEGF expression in occasional en-
dothelial cells was seen in both the control and EA-
affected tissues only in 2 cases.
In the control material, EGFR-containing cells, 
such as fibroblasts and macrophages, were found 
in moderate numbers, while in the EA-affected 
tissues, EGFR was detected in small-to-moderate 
number of inflammatory cells within blood vessels 
only in a few patients, but in most cases, the appear-
ance of EGFR was negative or insignificant in all 
other structures.
Fibroblasts, macrophages, endothelial cells, leu-
kocytes, and lymphocytes were positive for MMP-2. 
In the control tissues, this metalloproteinase marked 
numerous structures. The MMP-2 expression was 
weaker in the proximal part of the esophagus in 
EA-affected tissues as compared with controls. In 
the meantime, EA-affected tissues of the distal es-
ophageal part demonstrated MPP-2 expression even 
higher than in control material. 
In the control material, structures positive for 
NGFRp75, PGP 9.5, TGF-β, FGFR, and MMP-2 
were found to be numerous or abundant (Table). 
FGFR expression was similar in the distal and proxi-
mal parts of esophagus with EA as compared with 
control specimens. The number of PGP 9.5- and 
NGFRp75-containing neuronal structures was di-
minished in the proximal, but not in the distal part 
of the esophagus. Despite the fact that there were 
some variations in the expression of NGFR in the 
distal part of EA-affected esophagus, the appearance 
of the factor was similar to that in the control speci-

























Commonly, control specimens showed a similar relative occurrence of different factors from different parts of the esophagus, 
thus in the table shown as one value. *A statistically significant difference found between the groups by using of nonparametric 
statistics.
NGFRp75, nerve growth factor receptor p75; PGP 9.5, protein gene peptide 9.5; TGF-β, transforming growth factor beta; FGFR, 
fibroblast growth factor receptor; VEGF, vascular endothelial growth factor; EGFR, epidermal growth factor receptor; MMP-2, 
matrix metalloproteinase 2.
0, negative reaction; 0/+, occasionally marked structures in the view field; +, a few positive structures in the view field; ++, a 
moderate number of marked structures in the view field; +++, numerous marked structures in the view field; ++++, abundance 
of marked structures found in the view field.
Table. Relative Occurrence of Growth Factors, Their Receptors, Innervation Markers, and Tissue-Degradating Enzymes 
in Esophageal Atresia-Affected and Control Specimens
Factors in the Proximal and Distal Ends of the Esophagus in Children With Esophageal Atresia
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Fig. 1. Practically all basal epithelial cells show NGFR 
immunoreactivity in the control material 
(immunohistochemistry for NGFR, original magnification ×200)
Fig. 2. NGFR-containing nerve fiber bundles and nerve fibers 
among smooth muscle cells in the wall of small blood vessels 
in the control material (immunohistochemistry for NGFR, 
original magnification ×250)
Fig. 3. NGFR-containing nerve fiber bundles and nerve fibers 
among smooth muscle cells in wall of small blood vessels in 
the esophageal atresia-affected material 
(immunohistochemistry for NGFR, original magnification ×250)
Fig. 4. Regional conglomerate of basal epithelial cells weakly 
stained for NGFR
Note also numerous vacuolized epithelial cells 
(immunohistochemistry for NGFR, original magnification ×400)
Fig. 5. PGP 9.5-containing nerve bundles in the intermuscular 
plexus and among smooth muscle in the esophageal atresia-af-
fected specimen (immunohistochemistry for PGP 9.5, original 
magnification ×100)
Fig. 6. PGP 9.5-containing nerve trunks and nerve fibers near 
the wall of small blood vessels in the control material 
(immunohistochemistry for PGP 9.5, original 
magnification ×100)
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mens. The number of TGF-β-containing structures 
was notably decreased in the EA-affected tissue. 
EGFR expression was characteristic of control, but 
not of EA-affected tissue. There were no VEGF-
positive structures in the esophagus of either control 
or EA-affected patients. The same or higher num-
ber of MMP-2-positive cells was seen in the spec-
imens of the distal esophagus than in the control 
ones, while the specimens from the proximal part of 
the esophagus demonstrated a decreased number of 
MMP-2-positive cells.
Comparison of control and EA-affected speci-
mens of the esophagus revealed a significant dif-
ference in the relative number of TGF-β-positive 
(χ2=20.609; P=0.001), EGFR-positive (χ2=17.662; 
P=0.001), and MMP-2-positive (χ2=6.002; P=0.050) 
structures between control and proximal/distal es-
ophageal specimens. A significant difference in the 
structures positive for PGP 9.5 was observed be-
tween control/distal and proximal esophageal speci-
mens (χ2=7.847; P=0.020) (Table).
Discussion
In the EA-affected tissues, the number of PGP 
9.5-containing nerve fibers was lower compared with 
the control material. Generally, PGP 9.5 possesses 
intrinsic ligase and hydrolase activity necessary for 
a process of proteosomal protein degradation and 
supports the normal functioning of neuronal stuc-
tures (23). Therefore, the decreased amount of PGP 
9.5-positive structures might indicate a neuronal 
origin of the disorder. Interestingly, inherited in-
nervation disorders are mentioned also in a study 
by Qi et al. (1997), when branching abnormalities 
of the vagal nerve during embryogenesis result in 
nerve tissue deficiency particularly in the distal part 
of the esophagus. Such findings probably shed light 
to the abnormalities of esophageal motility estab-
lished in patients with EA/TEF before operative 
treatment (24).
As compared with the control material, the num-
ber of NGFR-expressing structures was also dimin-
ished in the EA-affected proximal esophagus. How-
ever, there was no significant difference comparing 
the specimens obtained from both parts of EA-af-
fected esophagus and control esophagus. According 
to the data reported by Bibel and Barde (25), NGFR 
binds not only NGF, but also other neurotrophins. 
Altogether, neurotrophins promote the formation 
of ceramides activating NGFR (26), but ceramides 
contribute to the protection of axonal structures and 
function. Thus, changes in NGFR expression might 
indicate damage to neuronal tissues. 
In EA-affected tissues, TGF-β-containing en-
dothelial cells were sparse. TGF-β is needed for 
the stabilization and further development of newly 
formed blood vessels (27). Diminished TGF-β ex-
pression very likely corresponds to cell prolifera-
tion, growth, and maturation abnormalities (14) as 
well as disorders of extracellular matrix formation. 
These disturbances, in turn, might lead to EA mani-
festation. 
FGFR marked abundant structures in both con-
trol and EA material. Fibroblasts, macrophages, 
lymphocytes, blood vessel endothelial cells, leu-
kocytes as well as nerve fibers expressed FGFR. In 
Fig. 8. TGF-β-containing endotheliocytes in the wall of blood 
vessels of the proximal esophageal pouch 
(TGF-β IMH, original magnification ×200)
Fig. 7. TGF-β-containing endothelial cells in the control 
material (TGF-β IMH, original magnification ×100)
Factors in the Proximal and Distal Ends of the Esophagus in Children With Esophageal Atresia
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other tissues of endodermal origin, for instance, 
healthy lung tissue, FGFR expression is spatially re-
stricted. Although in case of mesenchyme contact 
with Shh negative epithelium during embryogen-
esis, there is also described rich FGFR expression in 
wide area that possibly causes branching disorders 
(28). The abovementioned mechanism could ex-
plain the origin of distal esophagus or fistular tract 
growing caudally as straight, nonbranched structure 
showing an abundant FGFR expression (29). Fusion 
between fistular tract and developing stomach could 
therefore compensate and/or restore continuity of 
the gastrointestinal tract (30).
VEGF expression was negative both in the con-
trol and EA-affected tissues, with only occasional 
positively stained endothelial cells in some cases. 
VEGF stimulates the proliferation of endothe-
lial cells, particularly under hypoxia (16). A weak 
VEGF expression pattern is very likely explained 
by the most intensive angiogenesis in the course of 
embryogenesis, but our study material was obtained 
from newborns. It is interesting to note that VEGF 
possesses neurotrophic as well as neuroprotective 
properties (31). These VEGF properties and almost 
negative VEGF expression on the other hand might 
only partially explain the observed innervation dis-
orders in EA-affected tissues, because the negative 
expression of growth factor was observed also in the 
control tissues. On esophageal occlusion, including 
also EA, enhanced VEGF expression is observed in 
amnion and chorion and promotes intramembrane 
fetal fluid absorption into fetal circulation as well as 
decreases the likelihood of occurrence of polyhy-
dramnion (32).
EGFR-positive structures were found in mod-
erate numbers in the control specimens, while 
EA-affected tissues displayed insignificant or even 
negative expression patterns. EGFR is found in the 
tissues of epithelial, mesenchymal, and neuronal 
origin, where it contributes to cell proliferation, 
differentiation, and development (17). Therefore, 
EGFR expression abnormalities, which differed sta-
tistically significantly between the patient and con-
trol groups, might be one of the mechanisms behind 
EA development.
In the control material, MMP-2 marked many 
structures so that in the proximal part of the esopha-
gus, the number of positive structures was moder-
ate, whereas in the distal part of esophagus, MMP-
2-positive structures were numerous and abundant. 
MMP catalyzes extracellular matrix macromole-
cules, proteoglycans, and additional proteins such as 
fibronectin (33). According to the data of Okada et 
al. (2004), increased NGF expression comes along 
with increased MPP-2 expression (34). A decrease 
in NGFR-positive structures in our investigative 
material was often observed, but the difference be-
tween MMP-2 and NGFR relative occurrence was 
not proved to be significant. Nevertheless, in cases of 
denervation and diminished innervations, MMP-2 
expression was not changed substantially. A study by 
Kherif et al. reported an increased number of MMP-
2-positive cells observed in neuronal tissues with 
structural lesions indicating the role of MMP-2 in 
axonal degeneration and common regeneration (35). 
Conclusions
A decrease in PGP 9.5-containing neuronal 
structures in the proximal esophagus supports in-
sufficient innervation of this part of the organ in 
esophageal atresia. A decrease in MMP-2 positive 
cells in the esophageal atresia-affected proximal es-
ophagus indicates also a possible decrease of tissue 
adaptive and regenerative reactions. Low expression 
of TGF-β and almost the absence of EGFR in the 
esophageal atresia-affected specimens may deal with 
disturbances in cell growth, proliferation, and dif-
ferentiation, indicating a significant role of these 
substances in morphopathogenesis of esophageal 
atresia. FGFR and VEGF seem not to characterize 
esophageal atresia pathogenesis.
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fibroblastų augimo faktoriaus receptoriai 1 (FGFR1); kraujagyslių endotelio augimo faktoriai (VEGF); epi-
dermio augimo faktorių receptoriai (EGFR); matrikso metaloproteinazės-2 (MMP-2).
Rezultatai. Kontrolinės grupės ir pacientų, turinčių atreziją, stemplės distalinėjė dalyje NGFR p75 iš-
raiška buvo gausi, tuo tarpu pacientų stemplės proksimalinėje dalyje nustatytas receptorių turinčių struk-
tūrų skaičiaus sumažėjimas. Panašūs rezultai gauti įvertinant PGP 9,5 teigiamas struktūras. Esant atrezijai 
stemplėje aptiktos tik pavienės teigiamos TGF-b ląsteles, o kontrolinės grupės tiriamųjų tyrimo medžiagoje 
tokių ląstelių buvo vidutiniškai daug ir labai daug. Tiek kontrolinės, tiek pacientų grupės tiriamųjų stem-
plėse buvo aptikta daug FGFR, tuo tarpu VEGF buvo tik pavienėse ląstelėse. Tik kontrolinėje grupėje buvo 
aptikta vidutiniškai daug jungiamojo audinio ląstelių su EGFR. Skirtingai nei kontrolinėje grupėje, esant 
atrezijai, MMP-2 teigiamų ląstelių skaičius stemplės proksimalinėje dalyje buvo sumažėjęs.
Išvados. Stemplės proksimalinėje dalyje sumažėjusių PGP 9,5 teigiamų nervinių stuktūrų kiekis patvirti-
na nepakankamą šios dalies inervaciją esant atrezijai. Sumažėjęs MMP-2 teigiamų ląstelių skaičius stemplės 
proksimalinėje dalyje rodo galimai mažėjantį audinių prisitaikymą ir regeneraciją. Esant atrezijai, silpna 
TGF-b raiška ir beveik visiškas EGFR nebuvimas gali sąlygoti ląstelių augimo, proliferacijos bei diferenci-
acijos pažaidas. Atrodo, kad FGFR bei VEGF atrezijos patogenezėje nebūdingi.
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